GLYCOPYRROLATE

N/A

Manufactured by Merz Pharmaceuticals, LLC

19,591 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GLYCOPYRROLATE

GLYCOPYRROLATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Merz Pharmaceuticals, LLC. The most commonly reported adverse reactions for GLYCOPYRROLATE include DYSPNOEA, ASTHMA, WHEEZING, COUGH, PNEUMONIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYCOPYRROLATE.

Top Adverse Reactions

DYSPNOEA1,000 reports
ASTHMA793 reports
WHEEZING674 reports
COUGH626 reports
PNEUMONIA538 reports
DRUG INEFFECTIVE411 reports
FATIGUE352 reports
OFF LABEL USE351 reports
MALAISE345 reports
PRODUCTIVE COUGH330 reports
CHEST DISCOMFORT327 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE326 reports
CONDITION AGGRAVATED311 reports
NAUSEA311 reports
PYREXIA304 reports
WEIGHT DECREASED301 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE282 reports
FALL266 reports
VOMITING254 reports
GASTROOESOPHAGEAL REFLUX DISEASE252 reports
OBSTRUCTIVE AIRWAYS DISORDER243 reports
DEATH239 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES231 reports
NASOPHARYNGITIS229 reports
NASAL CONGESTION226 reports
ASTHENIA224 reports
FULL BLOOD COUNT ABNORMAL216 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION216 reports
DIARRHOEA209 reports
HEADACHE208 reports
BRONCHIECTASIS204 reports
PRODUCT USE IN UNAPPROVED INDICATION204 reports
DIZZINESS197 reports
DYSPNOEA EXERTIONAL196 reports
INFLUENZA187 reports
OEDEMA PERIPHERAL184 reports
TACHYCARDIA182 reports
SEIZURE178 reports
RHINORRHOEA175 reports
ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME169 reports
ARTHRALGIA167 reports
INSOMNIA165 reports
SPUTUM DISCOLOURED165 reports
PAIN163 reports
BLOOD PRESSURE INCREASED150 reports
NASAL POLYPS150 reports
ANXIETY148 reports
BRONCHITIS148 reports
HYPOTENSION148 reports
LOWER RESPIRATORY TRACT INFECTION148 reports
HYPERTENSION147 reports
OXYGEN SATURATION DECREASED145 reports
LUNG NEOPLASM MALIGNANT141 reports
WEIGHT INCREASED139 reports
UPPER RESPIRATORY TRACT INFECTION135 reports
PARAESTHESIA134 reports
CHEST PAIN133 reports
RHINITIS ALLERGIC132 reports
DRUG INTERACTION131 reports
PAIN IN EXTREMITY129 reports
PRODUCT DOSE OMISSION ISSUE128 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION127 reports
PRURITUS127 reports
INFECTION121 reports
GAIT DISTURBANCE120 reports
CARDIAC MURMUR119 reports
RESPIRATORY DISORDER119 reports
SARCOIDOSIS119 reports
TOTAL LUNG CAPACITY INCREASED118 reports
CONSTIPATION116 reports
SINUSITIS115 reports
CHOLELITHIASIS114 reports
SOMNOLENCE113 reports
HEART RATE INCREASED110 reports
CARDIAC ARREST107 reports
NEUROPATHY PERIPHERAL106 reports
HEPATIC ENZYME INCREASED105 reports
LUNG DISORDER105 reports
DEPRESSED MOOD104 reports
STRESS104 reports
DRUG INTOLERANCE102 reports
HYPERSENSITIVITY102 reports
PSYCHOTIC DISORDER101 reports
ILLNESS100 reports
MYALGIA100 reports
HYPOAESTHESIA99 reports
RESPIRATORY FAILURE99 reports
CARDIAC DISORDER97 reports
BLOOD BILIRUBIN INCREASED96 reports
BLOOD IMMUNOGLOBULIN E INCREASED96 reports
DEPRESSION94 reports
FORCED EXPIRATORY VOLUME DECREASED94 reports
HEPATOTOXICITY93 reports
BACK PAIN92 reports
JAUNDICE CHOLESTATIC92 reports
SCHIZOPHRENIA92 reports
DISCOMFORT90 reports
RASH90 reports
DYSPHONIA88 reports
URINARY TRACT INFECTION88 reports

Report Outcomes

Out of 5,223 classified reports for GLYCOPYRROLATE:

Serious 84.5%Non-Serious 15.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female2,550 (55.2%)
Male2,055 (44.5%)
Unknown15 (0.3%)

Reports by Age

Age 73140 reports
Age 52119 reports
Age 60110 reports
Age 6790 reports
Age 6188 reports
Age 6381 reports
Age 7279 reports
Age 6873 reports
Age 7572 reports
Age 5671 reports
Age 6971 reports
Age 7167 reports
Age 7466 reports
Age 4361 reports
Age 6260 reports
Age 5956 reports
Age 6656 reports
Age 7056 reports
Age 6555 reports
Age 7654 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYCOPYRROLATE?

This profile reflects 19,591 FDA FAERS reports that mention GLYCOPYRROLATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYCOPYRROLATE?

Frequently reported terms in FAERS include DYSPNOEA, ASTHMA, WHEEZING, COUGH, PNEUMONIA, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYCOPYRROLATE?

Labeling and FAERS entries often list Merz Pharmaceuticals, LLC in connection with GLYCOPYRROLATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.